Skip to main content
. 2018 Aug 31;8:174. doi: 10.1038/s41398-018-0230-7

Table 2.

PRS correlation with clinical variable during the baseline and the follow-up

Time Clinical variable N B p-value
Baseline (antipsychotic naive FEP) CGI 50 72.8 0.8436
a−GAF 48 436.1 0.0030
aCDSS total 51 1042.3 0.0039
PANSS total 53 38.1 0.6390
aPANSS positive 53 400.0 0.0278
PANSS negative 53 −205.6 0.3048
PANSS general psychopathology 53 −20.2 0.8886
Five-factor model21 PANSS negative 53 −168.2 0.2655
PANSS disorganization/cognition 53 −32.9 0.8281
bPANSS excitement 53 566.7 0.0003
PANSS positive 53 27.1 0.8382
PANSS depression/anxiety 53 −112.8 0.4761
Follow-up (9 weeks treated with risperidone) CGI 51 −137.4 0.7588
−GAF 53 −132.8 0.2281
bCDSS total 53 −1800.2 0.0004
PANSS total 54 −113.4 0.2215
PANSS positive 56 277.3 0.3141
PANSS negative 56 −358.3 0.0894
PANSS general psychopathology 54 −287.9 0.1140
Five-factor model21 PANSS negative 56 −180.6 0.2329
PANSS disorganization/cognition 56 −75.8 0.6608
PANSS excitement 56 216.4 0.3048
PANSS positive 56 10.0 0.9522
bPANSS depression/anxiety 55 −575.0 0.0013

PANSS Positive and Negative Syndrome Scale, CGI Clinical Global Impression Scale, GAF Global Assessment of Functioning Scale, CDSS Calgary Depression Scale for Schizophrenia

aSignificant p-values without Bonferroni correction

bSignificant p-values with Bonferroni correction